Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27773578 | 0.84 | ALDH1A1 (0.52) | ALDH1A1KDM4EGAANPC1RAB9A | |
| SCHEMBL6551386 | 0.83 | ALDH1A1 (0.55) | ALDH1A1KDM4EGAANPC1RAB9A | |
| SCHEMBL28362828 | 0.83 | ALDH1A1 (0.61) | ALDH1A1KDM4EGAANPC1RAB9A | |
| SCHEMBL194581 | 0.82 | ALDH1A1 (0.55) | ALDH1A1GAANPC1RAB9AMEN1 | |
| SCHEMBL10408109 | 0.82 | CES2 (0.52) | ALDH1A1KDM4EMAPTL3MBTL1TDP1 | |
| SCHEMBL23258930 | 0.81 | TPMT (0.42) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| SCHEMBL195428 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4ENPC1RAB9AMEN1 | |
| SCHEMBL28815026 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KDM4EGAANPC1RAB9A | |
| SCHEMBL29324398 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KDM4EGAANPC1RAB9A | |
| SCHEMBL20100374 | 0.79 | HDAC1 (0.56) | ALDH1A1NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010869-A | Dioxygen di-oxygen benzothiazepines Synthesis method of heptanone derivative | 新疆大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-122010870-A | Ester group substitution dibenzothio of (C) Synthesis method of azepine derivative | 新疆大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-118930483-A | Synthesis method of isoquinolone selenocyanate | 新疆大学 | 2024-11-12 | — | — | CN | disclosed |
| CN-118530176-A | Synthesis method of ester-substituted isoquinoline diketone and 3, 3-disubstituted indole oxide | 新疆大学 | 2024-08-23 | — | — | CN | disclosed |
| CN-114832862-B | Catalytic composition for coupling reaction and application of catalytic composition in preparation of isoquinoline-1, 3-dione compounds | 中国药科大学 | 2023-06-30 | — | — | CN | disclosed |
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11209733-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11204554-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-21 | — | — | US | disclosed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | disclosed |
| EP-3019473-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2020-02-19 | — | — | EP | disclosed |
| US-6596445-B1 | Initiators for photopolymerization of radically polymerizable compounds | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-07-22 | — | — | US | disclosed |
| WO-2003010602-A1 | PHOTOSENSITIVE RESIN COMPOSITION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-02-06 | — | — | WO | disclosed |
| WO-2002100903-A1 | OXIME ESTER PHOTOINITIATORS HAVING A COMBINED STRUCTURE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-12-19 | — | — | WO | disclosed |
| US-20020188084-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2002-12-12 | — | — | US | disclosed |
| US-20020020832-A1 | Photosensitive resin composition | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-21 | — | — | US | disclosed |
| US-20010012596-A1 | For resist applications; thermostability, storage stability | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-09 | — | — | US | disclosed |
| CN-1299812-A | Oximate light initiator | CIBA SC HOLDING AG (CH) | 2001-06-20 | — | — | CN | disclosed |
| CN-1241562-A | New O-acyloxime photointiators | CIBA SPECIALY CHEMICALS HOLDIN (CH) | 2000-01-19 | — | — | CN | disclosed |
| EP-0922715-A2 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 1999-06-16 | — | — | EP | disclosed |
| US-5663212-A | Light-sensitive resin composition | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | ALDH1A1 823/4885KDM4E 1549/4885GAA 4457/4885 |
| US-11204554-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | ALDH1A1 779/4885KDM4E 1583/4885GAA 4437/4885 |
| US-11209733-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | ALDH1A1 823/4885KDM4E 1549/4885GAA 4457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.